Business
What’s behind the sleepy Somnomed (ASX:SOM) share price? // The Motley Fool Australia

The Somnomed Limited (ASX: SOM) share price closed 2.3% lower today at $2.12.
While the SomnoMed share price has bounced back 67.5% over the past half year, it still remains more than 11% down on this time last year. We take a closer look at what’s been impacting the healthcare equipment company’s share price.
2020 financial year highlights
The Somnomed AGM presentation from November 2020 draws attention to strong growth in the US and new sales leadership heading up Canada. New key appointments were also announced in Sydney.
Somnomed continued to promote the company’s continuous open airway therapy (COAT) technology as a best-in-class treatment for sleep apnea. The company did not offer FY 2021 guidance in its latest report,…
-
Business17 hours ago
Why did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours ago
Own Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours ago
Patients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business16 hours ago
Here’s what analysts expect for the BHP share price in the coming year